Key result
Implantable cardioverter-defibrillators consistently produce a 20-30% reduction in total mortality in post-myocardial infarction patients with left ventricular dysfunction.
Why the study?
Does ICD implantation reduce mortality in post-myocardial infarction patients with left ventricular dysfunction?
Population
Post-myocardial infarction patients with left ventricular dysfunction and either demonstrated or anticipated…
Design
Review
Authors
Loading...
Affirms ICD mortality benefit in post-MI LV dysfunction; extends evidence but leaves generalizability and implementation open.
Does ICD implantation reduce mortality in post-myocardial infarction patients with left ventricular dysfunction?
Effect estimate: 20-30% reduction
ICDs provide a consistent 20-30% reduction in total mortality for post-MI patients with LV dysfunction, though they remain underutilized and carry risks such as inappropriate shocks.
Pande et al. (2015) conducted a review in Post-myocardial infarction with left ventricular dysfunction and risk for arrhythmic death. Implantable cardioverter-defibrillators (ICDs) was evaluated on Total mortality (20-30% reduction). Implantable cardioverter-defibrillators consistently produce a 20-30% reduction in total mortality in post-myocardial infarction patients with left ventricular dysfunction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: